Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Very Low Calorie Diet

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT06027567Phase 4Completed

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Showing all 1 trials

Research Network

Common Treatments

  • Very Low Calorie Diet1
  • Semaglutide1
  • Dietician Counselling1

Active Sponsors

  • University of Copenhagen1
  • Rigmor Højland Jensen1
  • Copenhagen University Hospital, Rigshospitalet1
  • Odense University Hospital1

Top Investigators

Related Conditions

  • Papilledema1
  • Idiopathic Intracranial Hypertension1
  • Weight Loss1
  • Obesity1
  • Intracranial Pressure1

Activity Timeline